Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/7/17 → 6/9/21 |
Funding
- AbbVie Incorporated: $46,860.00
M15-991 a MultiCenter Randomized Double Blind Placebo Controlled Induction Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Chron's Disease Who Failed Prior Biologic Treatment
- Flomenhoft, Deborah (PI)